Cerebral cortex: a target and source of insulin?

Diabetologia

Volumn 59, Issue 8, 2016, Pages 1609-1615

  Csajbók, Éva A ^a   Tamás, Gábor ^b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Animal; Basic science; Human; Insulin action; Insulin synthesis; Rat; Review

Indexed keywords

4 AMINOBUTYRIC ACID; GLIBENCLAMIDE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; INSULIN; INSULIN RECEPTOR;

AUTOTRANSPLANTATION; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN NERVE CELL; CEREBROSPINAL FLUID; CHOROID PLEXUS; DIABETES MELLITUS; ENERGY METABOLISM; FOOD INTAKE; GLUCOSE TRANSPORT; HIPPOCAMPUS; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN SYNTHESIS; INTERNEURON; INTERSTITIAL FLUID; NERVE CELL NETWORK; NEURAL STEM CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; AGONISTS; ANIMAL; METABOLISM;

ANIMALS; CEREBRAL CORTEX; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN;

EID: 84969822922     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-016-3996-2     Document Type: Review

References (85)

1. Banting FG, Best CH (1922) The internal secretion of the pancreas. J Lab Clin Med 7:465–480
2. Mueckler M (1994) Facilitative glucose transporters. Eur J Biochem 219:713–725
3. Havrankova J, Roth J, Brownstein M (1978) Insulin receptors are widely distributed in the central nervous system of the rat. Nature 272:827–829
4. Wozniak M, Rydzewski B, Baker SP, Raizada MK (1993) The cellular and physiological actions of insulin in the central nervous system. Neurochem Int 22:1–10
5. Unger J, McNeill TH, Moxley RT 3rd et al (1989) Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience 31:143–157
6. Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799–806
7. Niswender KD, Morrison CD, Clegg DJ et al (2003) Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia. Diabetes 52:227–231
8. Banks WA, Owen JB, Erickson MA (2012) Insulin in the brain: there and back again. Pharmacol Ther 136:82–93
9. Gerozissis K (2010) The brain-insulin connection, metabolic diseases and related pathologies. In: Craft S (ed) Diabetes, insulin and Alzheimer's disease. Springer, Berlin, pp 21–42
10. Gray SM, Meijer RI, Barrett EJ (2014) Insulin regulates brain function, but how does it get there? Diabetes 63:3992–3997
11. McNay EC, Recknagel AK (2011) Brain insulin signaling: a key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes. Neurobiol Learn Mem 96:432–442
12. Ghasemi R, Haeri A, Dargahi L et al (2013) Insulin in the brain: sources, localization and functions. Mol Neurobiol 47:145–171
13. Gerozissis K, Kyriaki G (2003) Brain insulin: regulation, mechanisms of action and functions. Cell Mol Neurobiol 23:1–25
14. Bondareva VM, Chistyakova OV (2007) Insulin and insulin-receptor signaling in the brain. Neurochem J 1:176–187
15. Margolis RU, Altszuler N (1967) Insulin in the cerebrospinal fluid. Nature 215:1375–1376
16. Banks WA, Jaspan JB, Kastin AJ (1997) Selective, physiological transport of insulin across the blood-brain barrier: novel demonstration by species-specific radioimmunoassays. Peptides 18:1257–1262
17. Strubbe JH, Porte D, Woods SC (1988) Insulin responses and glucose levels in plasma and cerebrospinal fluid during fasting and refeeding in the rat. Physiol Behav 44:205–208
18. Wallum BJ, Taborsky GJ, Porte D et al (1987) Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man. J Clin Endocrinol Metab 64:190–194
19. Kern W, Benedict C, Schultes B et al (2006) Low cerebrospinal fluid insulin levels in obese humans. Diabetologia 49:2790–2792
20. Schwartz MW, Sipols A, Kahn SE et al (1990) Kinetics and specificity of insulin uptake from plasma into cerebrospinal fluid. Am J Physiol 259:E378–383
21. Dietrich MO, Spuch C, Antequera D et al (2008) Megalin mediates the transport of leptin across the blood-CSF barrier. Neurobiol Aging 29:902–912
22. Orlando RA, Rader K, Authier F et al (1998) Megalin is an endocytic receptor for insulin. J Am Soc Nephrol 9:1759–1766
23. Genders AJ, Frison V, Abramson SR, Barrett EJ (2013) Endothelial cells actively concentrate insulin during its transendothelial transport. Microcirculation 20:434–439
24. Wang H, Wang AX, Barrett EJ (2011) Caveolin-1 is required for vascular endothelial insulin uptake. Am J Physiol Endocrinol Metab 300:E134–144
25. Wang H, Wang AX, Liu Z, Barrett EJ (2008) Insulin signaling stimulates insulin transport by bovine aortic endothelial cells. Diabetes 57:540–547
26. Wang H, Wang AX, Aylor K, Barrett EJ (2013) Nitric oxide directly promotes vascular endothelial insulin transport. Diabetes 62:4030–4042
27. Iliff JJ, Wang M, Liao Y et al (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med 4:147ra111
28. Orosco M, Gerozissis K, Rouch C, Nicolaïdis S (1995) Feeding-related immunoreactive insulin changes in the PVN-VMH revealed by microdialysis. Brain Res 671:149–158
29. Gerozissis K, Orosco M, Rouch C, Nicolaidis S (1997) Insulin responses to a fat meal in hypothalamic microdialysates and plasma. Physiol Behav 62:767–772
30. Born J, Lange T, Kern W et al (2002) Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci 5:514–516
31. Banks WA, Kastin AJ (1998) Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin. Peptides 19:883–889
32. Pardridge WM, Eisenberg J, Yang J (1985) Human blood-brain barrier insulin receptor. J Neurochem 44:1771–1778
33. Reger MA, Watson GS, Green PS et al (2008) Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology 70:440–448
34. Craft S, Baker LD, Montine TJ et al (2012) Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol 69:29–38
35. Steen E, Terry BM, Rivera EJ et al (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease—is this type 3 diabetes? J Alzheimers Dis 7:63–80
36. Craft S, Peskind E, Schwartz MW et al (1998) Cerebrospinal fluid and plasma insulin levels in Alzheimer’s disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology 50:164–168
37. Lochhead JJ, Thorne RG (2012) Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev 64:614–628
38. Salameh TS, Bullock KM, Hujoel IA et al (2015) Central nervous system delivery of intranasal insulin: mechanisms of uptake and effects on cognition. J Alzheimers Dis 47:715–728
39. Havrankova J, Schmechel D, Roth J, Brownstein M (1978) Identification of insulin in rat brain. Proc Natl Acad Sci U S A 75:5737–5741
40. Baskin DG, Stein LJ, Ikeda H et al (1985) Genetically obese Zucker rats have abnormally low brain insulin content. Life Sci 36:627–633
41. Banks WA (2004) The source of cerebral insulin. Eur J Pharmacol 490:5–1242
42. Di Guglielmo GM, Drake PG, Baass PC et al (1998) Insulin receptor internalization and signalling. Mol Cell Biochem 182:59–63
43. Dorn A, Bernstein HG, Rinne A et al (1983) Insulin- and glucagonlike peptides in the brain. Anat Rec 207:69–77
44. Dorn A, Rinne A, Bernstein HG et al (1983) Insulin and C-peptide in human brain neurons (insulin/C-peptide/brain peptides/immunohistochemistry/radioimmunoassay). J Hirnforsch 24:495–499
45. Kuwabara T, Kagalwala MN, Onuma Y et al (2011) Insulin biosynthesis in neuronal progenitors derived from adult hippocampus and the olfactory bulb. EMBO Mol Med 3:742–754
46. Birch NP, Christie DL, Renwick AG (1984) Proinsulin-like material in mouse foetal brain cell cultures. FEBS Lett 168:299–302
47. Devaskar SU, Singh BS, Carnaghi LR et al (1993) Insulin II gene expression in rat central nervous system. Regul Pept 48:55–63
48. Devaskar SU, Giddings SJ, Rajakumar PA et al (1994) Insulin gene expression and insulin synthesis in mammalian neuronal cells. J Biol Chem 269:8445–8454
49. Deltour L, Leduque P, Blume N et al (1993) Differential expression of the two nonallelic proinsulin genes in the developing mouse embryo. Proc Natl Acad Sci U S A 90:527–531
50. Mehran AE, Templeman NM, Brigidi GS et al (2012) Hyperinsulinemia drives diet-induced obesity independently of brain insulin production. Cell Metab 16:723–737
51. Faragó N, Kocsis ÁK, Lovas S et al (2013) Digital PCR to determine the number of transcripts from single neurons after patch-clamp recording. Biotechniques 54:327–336
52. Molnár G, Faragó N, Kocsis ÁK et al (2014) GABAergic neurogliaform cells represent local sources of insulin in the cerebral cortex. J Neurosci 34:1133–1137
53. Vannucci SJ, Koehler-Stec EM, Li K et al (1998) GLUT4 glucose transporter expression in rodent brain: effect of diabetes. Brain Res 797:1–11
54. Reagan LP (2005) Neuronal insulin signal transduction mechanisms in diabetes phenotypes. Neurobiol Aging 26(Suppl 1):56–59
55. Hirvonen J, Virtanen KA, Nummenmaa L et al (2011) Effects of insulin on brain glucose metabolism in impaired glucose tolerance. Diabetes 60:443–447
56. Baker LD, Cross DJ, Minoshima S et al (2011) Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol 68:51–57
57. Bingham EM, Hopkins D, Smith D et al (2002) The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study. Diabetes 51:3384–3390
58. Emmanuel Y, Cochlin LE, Tyler DJ et al (2013) Human hippocampal energy metabolism is impaired during cognitive activity in a lipid infusion model of insulin resistance. Brain Behav 3:134–144
59. McNay EC, Ong CT, McCrimmon RJ et al (2010) Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance. Neurobiol Learn Mem 93:546–553
60. Gregg EW, Yaffe K, Cauley JA et al (2000) Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med 160:174–180
61. Elias PK, Elias MF, D’Agostino RB et al (1997) NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study. Diabetes Care 20:1388–1395
62. Craft S, Watson GS (2004) Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 3:169–178
63. Chiu S-L, Cline HT (2010) Insulin receptor signaling in the development of neuronal structure and function. Neural Dev 5:7
64. Beattie EC, Carroll RC, Yu X et al (2000) Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD. Nat Neurosci 3:1291–1300
65. Lin JW, Ju W, Foster K et al (2000) Distinct molecular mechanisms and divergent endocytotic pathways of AMPA receptor internalization. Nat Neurosci 3:1282–1290
66. van der Heide LP, Kamal A, Artola A et al (2005) Insulin modulates hippocampal activity-dependent synaptic plasticity in a N-methyl-d-aspartate receptor and phosphatidyl-inositol-3-kinase-dependent manner. J Neurochem 94:1158–1166
67. Wan Q, Xiong ZG, Man HY et al (1997) Recruitment of functional GABA(A) receptors to postsynaptic domains by insulin. Nature 388:686–690
68. Jin Z, Jin Y, Kumar-Mendu S et al (2011) Insulin reduces neuronal excitability by turning on GABA(A) channels that generate tonic current. PLoS One 6:e16188
69. Tamas G, Lorincz A, Simon A, Szabadics J (2003) Identified sources and targets of slow inhibition in the neocortex. Science 299:1902–1905
70. Olah S, Fule M, Komlosi G et al (2009) Regulation of cortical microcircuits by unitary GABA-mediated volume transmission. Nature 461:1278–1281
71. Spanswick D, Smith MA, Mirshamsi S et al (2000) Insulin activates ATP-sensitive K+ channels in hypothalamic neurons of lean, but not obese rats. Nat Neurosci 3:757–758
72. Stefani MR, Gold PE (2001) Intrahippocampal infusions of K-ATP channel modulators influence spontaneous alternation performance: relationships to acetylcholine release in the hippocampus. J Neurosci 21:609–614
73. Piroli GG, Grillo CA, Reznikov LR et al (2007) Corticosterone impairs insulin-stimulated translocation of GLUT4 in the rat hippocampus. Neuroendocrinology 85:71–80
74. Hamilton A, Hölscher C (2009) Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system. Neuroreport 20:1161–1166
75. Korol SV, Jin Z, Babateen O, Birnir B (2015) GLP-1 and exendin-4 transiently enhance GABAA receptor-mediated synaptic and tonic currents in rat hippocampal CA3 pyramidal neurons. Diabetes 64:79–89
76. Holst JJ (2007) The physiology of glucagon-like peptide 1. Physiol Rev 87:1409–1439
77. Lovshin JA, Drucker DJ (2009) Incretin-based therapies for type 2 diabetes mellitus. Nat Rev Endocrinol 5:262–269
78. Anthony K, Reed LJ, Dunn JT et al (2006) The cerebral basis for impaired control of food intake in metabolic syndrome. Diabetes 55:2986–2992
79. Heni M, Kullmann S, Preissl H et al (2015) Impaired insulin action in the human brain: causes and metabolic consequences. Nat Rev Endocrinol 11:701–711
80. Kleinridders A, Ferris HA, Cai W, Kahn CR (2014) Insulin action in brain regulates systemic metabolism and brain function. Diabetes 63:2232–2243
81. McClean PL, Hölscher C (2014) Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer’s disease. Neuropharmacology 76:57–67
82. Duarte AI, Candeias E, Correia SC et al (2013) Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration. Biochim Biophys Acta 1832:527–541
83. Basak O, Clevers H (2011) Neural stem cells for diabetes cell-based therapy. EMBO Mol Med 3:698–700
84. Kuwabara T, Asashima M (2012) Regenerative medicine using adult neural stem cells: the potential for diabetes therapy and other pharmaceutical applications. J Mol Cell Biol 4:1–2
85. Pagano SF, Impagnatiello F, Girelli M et al (2000) Isolation and characterization of neural stem cells from the adult human olfactory bulb. Stem Cells 18:295–300